Results 131 to 140 of about 4,378 (208)

Infantile Fibrosarcoma of the Hand: Limb-Sparing Treatment With Modern Targeted Oral Chemotherapy and Conservative Surgical Resection. [PDF]

J Hand Surg Glob Online
Vaile JR, Tipps JA, Hurley R, Struble SL, Allen BE, Surrey LF, Finn LS, Balis FM, Laetsch TW, Mendenhall SD.   +9 more
europepmc   +1 more source

The Utility of Tissue-Agnostic Drugs in Lung Cancer Treatment. [PDF]

Pharmaceut Med
Kong L, Grobman B, Mansur A, Lee A, Bondarchuk C, Erdogan H, Lu CY.   +6 more
europepmc   +1 more source

628P Efficacy and safety of larotrectinib as first-line treatment for patients (pts) with TRK fusion cancer: An updated analysis [PDF]

D.S. Hong, R-H. Xu, L. Shen, Miranda P. Dierselhuis, Daniel Orbach, Ray McDermott, Antoîne Italiano, Makoto Tahara, Vadim Bernard-Gauthier, Nikolaus Neu, C.E. Mussi, E.A. De La Cuesta, T. Laetsch, A.E. Drilon   +13 more
openalex   +1 more source

Larotrectinib (Vitrakvi®)

Oncology Times, 2019
openaire   +2 more sources

OP01-5 Efficacy and safety of larotrectinib in NTRK fusion-positive solid tumor patients: A multi-center retrospective study

ESMO Open
S. Lee, S.J. Park, K. Shin, H. Jung, S. Park, Y. Lee, W. Choi, H.S. Kim, C.G. Kim, H.R. Kim, S.B. Bae, K. Lee, K-W. Lee, E. Kang, S. Yoon, D. Lim, J.H. Kang   +16 more
semanticscholar   +1 more source

A Systematic Review with a Demonstrative Case of KIT and DOG-1 Expressing Gastrointestinal Stromal Tumors Harboring ETV6-NTRK3 Fusions. [PDF]

Clin Cancer Res
Ranjbarian T, Antkowiak M, Mallory RJ, Doherty TM, Hosseini M, Mesirov JP, Fanta PT, Sicklick JK.   +7 more
europepmc   +1 more source

Current management of neurotrophic receptor tyrosine kinase fusion-positive sarcoma: an updated review. [PDF]

Jpn J Clin Oncol
Kubota Y, Kawano M, Iwasaki T, Itonaga I, Kaku N, Ozaki T, Tanaka K.   +6 more
europepmc   +1 more source

Calculated values of entropy indices of Erbitux and Larotrectinib.

Maria Fazal (21688880), Salma Kanwal (17276643), Muhammad Taskeen Raza (21688883), Asima Razzaque (20521431)   +3 more
openalex   +1 more source

Faculty Opinions recommendation of Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.

, 2018
David M. Parham
openalex   +2 more sources

On TRacK With Larotrectinib in a Neonate With a Giant Congenital ETV6::NTRK3 Fusion-Positive Infantile Fibrosarcoma of the Head and Neck. [PDF]

Head Neck
Cardesa-Salzmann TM, Sparber-Sauer M, Hingst P, Erbersdobler A, Schneider B, Hühns M, Jakob A, Terpe F, Spang C, Stalmann D, Bierwirth C, Hauenstein C, Märzheuser S, Ballmann M, Classen CF.   +14 more
europepmc   +1 more source